Barclays set a €38.50 ($44.77) target price on Siemens Healthineers (ETR:SHL) in a research note published on Friday morning, Borsen Zeitung reports. The brokerage currently has a neutral rating on the stock.

A number of other equities analysts have also weighed in on SHL. Morgan Stanley set a €37.00 ($43.02) price objective on Siemens Healthineers and gave the stock a neutral rating in a research note on Thursday, September 12th. UBS Group set a €37.00 ($43.02) price objective on Siemens Healthineers and gave the stock a neutral rating in a research note on Friday, August 9th. Berenberg Bank set a €42.00 ($48.84) price objective on Siemens Healthineers and gave the stock a buy rating in a research note on Friday, July 12th. Independent Research set a €38.00 ($44.19) price objective on Siemens Healthineers and gave the stock a neutral rating in a research note on Friday, August 16th. Finally, HSBC set a €41.00 ($47.67) price objective on Siemens Healthineers and gave the stock a neutral rating in a research note on Tuesday, August 13th. One research analyst has rated the stock with a sell rating, thirteen have issued a hold rating and four have assigned a buy rating to the company’s stock. Siemens Healthineers currently has a consensus rating of Hold and a consensus price target of €38.14 ($44.34).

ETR SHL opened at €35.81 ($41.63) on Friday. The firm has a market cap of $35.81 billion and a price-to-earnings ratio of 25.06. The company has a quick ratio of 0.87, a current ratio of 1.30 and a debt-to-equity ratio of 55.12. The business has a 50-day moving average price of €35.98 and a 200-day moving average price of €36.66. Siemens Healthineers has a twelve month low of €31.90 ($37.09) and a twelve month high of €39.21 ($45.59).

Siemens Healthineers Company Profile

Siemens Healthineers AG develops, manufactures, and distributes imaging, advanced therapies, and diagnostic products and services to healthcare providers worldwide. It operates in three operating segments: Imaging, Advanced Therapies, and Diagnostics. The Imaging segment provides diagnostic imaging and ultrasound systems and solutions.

See Also: Moving Average – How it Helps Investors in Stock Selection

Analyst Recommendations for Siemens Healthineers (ETR:SHL)

Receive News & Ratings for Siemens Healthineers Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Siemens Healthineers and related companies with MarketBeat.com's FREE daily email newsletter.